Quarterly report · Q2
2931.TEDINET S100RO90
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.8bn | 2023-01-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥44.4bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥21.6bn | 2022-01-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | −¥760m | 2023-01-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | −¥1.4bn | 2022-01-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | −¥639m | 2023-01-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | −¥2.5bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥597m | 2022-01-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | −¥618m | 2023-01-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | −¥595m | 2022-01-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥914m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.7bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥465m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥913m | 2023-01-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | −¥462m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥60.8bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥57.3bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥58.6bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.1bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥37.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥21.7bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.4bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.9bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥16.3bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.0bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥16.2bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.8bn | at 2021-12-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥500m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥924m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥351m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.2bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥531m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥6.2bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-7.88 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.38 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-23.83 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.18 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.54 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 35.7% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-06-30 | −¥862m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥901m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥432m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥20.5bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥724m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2023-01-01 → 2023-06-30 | −¥189m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-01-01 → 2023-06-30 | ¥22.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-01-01 → 2023-06-30 | ¥101m |
| Reconciling Itemsreconciling | segment profit | 2022-01-01 → 2022-06-30 | −¥810m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥63m |
| jpcrp040300-q2r_E27054-000Biofuel Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥376m |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥20.2bn |
| jpcrp040300-q2r_E27054-000Health Care Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥122m |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E27054-000Others Businessreportable segment | segment profit | 2022-01-01 → 2022-06-30 | −¥113m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-01-01 → 2022-06-30 | ¥21.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-01-01 → 2022-06-30 | −¥611m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 627
| Item | Context | Value | Unit |
|---|---|---|---|
| Income before income taxes | Prior1YTDDuration | -595000000 | JPY |
| Income before income taxes | CurrentYTDDuration | -618000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 1169000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 1255000000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 405000000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 423000000 | JPY |
| Share based compensation expenses ope cf | Prior1YTDDuration | 57000000 | JPY |
| Share based compensation expenses ope cf | CurrentYTDDuration | 59000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | 5000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | Prior1YTDDuration | -2000000 | JPY |
| Loss gain on sales of property plant and equipment ope cf | CurrentYTDDuration | -25000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -10000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 19000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -75000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -103000000 | JPY |
| Increase decrease in provision for retirement benefits and directors retirement benefits ope cf | Prior1YTDDuration | -19000000 | JPY |
| Increase decrease in provision for retirement benefits and directors retirement benefits ope cf | CurrentYTDDuration | 3000000 | JPY |
| Increase decrease in provision for business structure improvement ope cf | Prior1YTDDuration | -31000000 | JPY |
| Increase decrease in provision for business structure improvement ope cf | CurrentYTDDuration | － | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -0 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -1000000 | JPY |
| Subsidy income2 ope cf | Prior1YTDDuration | -688000000 | JPY |
| Subsidy income2 ope cf | CurrentYTDDuration | -303000000 | JPY |
| Gain on reversal of subscription rights to shares ope cf | Prior1YTDDuration | -0 | JPY |
| Gain on reversal of subscription rights to shares ope cf | CurrentYTDDuration | -1000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 275000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 242000000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -3000000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | 0 | JPY |
| Stock issuance cost ope cf | Prior1YTDDuration | － | JPY |
| Stock issuance cost ope cf | CurrentYTDDuration | 37000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | -35000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | 8000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 277000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 577000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | 1010000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | 425000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -107000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -321000000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -45000000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -606000000 | JPY |
| Decrease increase in consumption taxes receivable payable ope cf | Prior1YTDDuration | 183000000 | JPY |
| Decrease increase in consumption taxes receivable payable ope cf | CurrentYTDDuration | 142000000 | JPY |
| Other net ope cf | Prior1YTDDuration | -401000000 | JPY |
| Other net ope cf | CurrentYTDDuration | -41000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 1361000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 1178000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 0 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 1000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |